PSI Sci
New here? Follow the money and the votes · Not sure of your district? Find your U.S. House member · Find your state legislators

H.R. 6000: Cures 2.0 Act

Before you vote › Federal bills

H.R. 6000: Cures 2.0 Act

117th Congress · introduced 2021-11-17 · Health · Latest: Referred to the Subcommittee on Biotechnology, Horticulture, and Research.

federal

Follow this bill, step by step

  1. Where it came from: introduced 2021-11-17 · official record
  2. Who proposed it: Rep. DeGette, Diana [D-CO-1] · what a sponsor is
  3. What happened next: no floor votes in our records yet. Why?
  4. Where it stands now: Referred to the Subcommittee on Biotechnology, Horticulture, and Research. Not final yet: this can still change. We check for updates every day.
  5. If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.

What does this mean?

Official title

Cures 2.0 Act

Plain summary

Cures 2.0 Act This bill addresses pandemic preparedness and public health issues, caregiver and patient engagement, drug development, insurance coverage, and biomedical research. The Department of Health and Human Services (HHS) must undertake research and other activities concerning COVID-19 and develop a strategy for future pandemics and declared emergencies. Additionally, the bill specifies actions to combat antimicrobial resistance. HHS may award grants for caregiver training. The bill also addresses diversity in clinical trials, collecting patient experience data during clinical trials, and coverage for care related to participation in specified clinical trials. The bill modifies the timeframe and requires additional guidance relating to expedited approval of certain breakthrough drugs, devices, or products. It also establishes two intercenter institutes within the Food and Drug Administration (FDA) focused on particular diseases that meet specified criteria. The bill also addresses (1) coverage in Medicare, Medicaid, and the Children's Health Insurance Program for telehealth, genetic and genomic testing, and other services; (2) electronic prescribing standards for Medicare drug benefits; and (3) access to Medicare and Medicaid claims data by certain registries. Furthermore, the bill prohibits the use of geographic tracking or biometrics in Medicaid electronic visit verification systems. The bill establishes the Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health to accelerate biomedical research and innovation through grants, contracts, cash prizes, and other means. The FDA may work with ARPA-H to expedite the development of medical products through specified activities.

Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.

What a vote does

A “Yea” vote

If it passes both chambers and is signed, it becomes law.

A “Nay” vote

If it is not passed, current law stays as it is.

PSI Sci description of the legislative step (not an opinion).

What does this mean? (plain words)

Official text

Cures 2.0 Act

Source: Congressional Research Service summary (Introduced in House)

AI explanation – may be wrong, check the official text

No AI explanation yet. It takes up to a minute to write and is then saved for everyone.

Limited to a few requests an hour per person.

The strongest published arguments

Arguments for (supporters)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Arguments against (opponents)

Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.

Alternatives

Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.

How did my representative vote? · This bill's floor votes

Officials and money

Sponsor: Rep. DeGette, Diana [D-CO-1] · 100 cosponsors

Cost estimate: No cost estimate published yet.

Cosponsors on this site

Brian K. Fitzpatrick (R-PA), Mark DeSaulnier (D-CA), Tom Cole (R-OK), Vern Buchanan (R-FL), Kweisi Mfume (D-MD), Henry Cuellar (D-TX), Lois Frankel (D-FL), Kim Schrier (D-WA), Donald S. Beyer, Jr. (D-VA), Nanette Diaz Barragán (D-CA), Joyce Beatty (D-OH), Lisa Blunt Rochester (D-DE), Yvette D. Clarke (D-NY), Steve Cohen (D-TN), Marcy Kaptur (D-OH), Lori Trahan (D-MA), Jerrold Nadler (D-NY), Joe Neguse (D-CO), Bennie G. Thompson (D-MS), André Carson (D-IN), Emanuel Cleaver (D-MO), Debbie Dingell (D-MI), Dwight Evans (D-PA), Steven Horsford (D-NV), Henry C. "Hank" Johnson, Jr. (D-GA), Robin L. Kelly (D-IL), Ed Case (D-HI), Michael T. McCaul (R-TX), Darren Soto (D-FL), J. French Hill (R-AR), Deborah K. Ross (D-NC) and 40 more.

Sponsor's campaign money: Rep. DeGette, Diana [D-CO-1] reported raising $1.7 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.

No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.

Words on this page, explained (1)
Bill
A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).

Plain meanings written from linked sources. All words.

Sources

Record fed-us-cong117-hr6000 · catalog fed-us-congress-bills-cong117 · updated 2026-11-15 by psicol fed-bills-cong117